Literature DB >> 10274168

Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program.

P E MacCosbe, G Gartenberg.   

Abstract

Initial experience with one strategy to modify selection of empiric antibiotic therapy by medical residents in presented. New orders for parenteral antibiotics written by residents before receiving culture results were randomly allocated to either a recommendation or a control group. Antibiotic orders from each group were compared with guidelines for antibiotic selection, and suggestions to change antibiotics were made only for orders from the recommendation group that did not match the guidelines. Recommendations for change appeared necessary for about 20% of the orders within each group. At follow-up, 78% of these orders had been changed as suggested in the recommendation group, whereas only 10% of the orders in the control group were changed (p less than 0.005). The mean difference in daily cost per order was a savings of $27.40 in the recommendation group and only $1.11 in the control group (p less than 0.01).

Mesh:

Substances:

Year:  1985        PMID: 10274168

Source DB:  PubMed          Journal:  Hosp Formul        ISSN: 0098-6909


  3 in total

Review 1.  Systematic review of economic evaluations and cost analyses of guideline implementation strategies.

Authors:  Luke Vale; Ruth Thomas; Graeme MacLennan; Jeremy Grimshaw
Journal:  Eur J Health Econ       Date:  2007-03-09

Review 2.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  Peter Davey; Charis A Marwick; Claire L Scott; Esmita Charani; Kirsty McNeil; Erwin Brown; Ian M Gould; Craig R Ramsay; Susan Michie
Journal:  Cochrane Database Syst Rev       Date:  2017-02-09

3.  The relationship between organisational characteristics and the effects of clinical guidelines on medical performance in hospitals, a meta-analysis.

Authors:  Rob Dijkstra; Michel Wensing; Ruth Thomas; Reinier Akkermans; Joze Braspenning; Jeremy Grimshaw; Richard Grol
Journal:  BMC Health Serv Res       Date:  2006-04-28       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.